Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Dr Fabien Praz
Dr Fabien Praz is an interventional cardiologist at Bern University Hospital, Switzerland. His top areas of expertise are Mitral Valve Regurgitation, Tricuspid Regurgitation, Mitral Stenosis, and Aortic Valve Stenosis. View more
Chad Kliger
Job title: Director, Structural Heart Disease of Cardiovascular Medicine
Division of Structural and Congenital Heart Disease, Lenox Hill Heart and Vascular Institute – North Shore/LIJ Health System, New York, US. Dr Chad A Kliger serves as Associate Editor for US Cardiology Review. View more
Francesco Maisano
Research Area(s) / Expertise:

Intervention

 Job title: Head of Cardiac Surgery, Director of the Valve Center
Prof Maisano is Professor of Cardiac Surgery and Director of the Valve Center at San Raffaele Research Hospital in Milan. Prof Maisano is acardiac surgeon with large experience in standard cardiovascular treatments and innovative technologies, as well as cross-trained in interventional cardiology, with specific focus on structural interventions. In his research, Prof Maisano was the… View more
TCT 2022 Late-Breaking Science Collection
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
Stay up-to-date with our regular review series, View from the Thoraxcenter hosted byProf Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this #TCT2022 edition they provide a short analysis of the most pertinent data from 15 late-breaking science presentations. Short, accessibleExpert Interviewswere conducted with investigators focusing on study design, key… View more

Intervention
Author(s): Michael Hoebartner , Philipp Kiefer , Michael Andrew Borger , et al Added: 3 years ago
Mitral valve regurgitation (MR) is frequently induced by degenerative mitral valve (MV) disease and leads to leaflet prolapse. Therefore, valve repair is a well-proven surgical technique with excellent long-term outcomes.1–5 The risk of declining left ventricle (LV) function or LV enlargement and the development of atrial fibrillation or severe pulmonary hypertension due to chronic volume… View more

Intervention

Vascular Disease and Surgery
Atrioventricular (AV) Valves Summit 2023
Added: 5 months ago
In this series of short interviews and discussions filmed at AV Valves Summit 2023, the faculty delve into sharing invaluable insights and expert opinion on transcathetermitral and tricuspid intervention. They examine a range of topics which include the development of TEER, the importance of quality of life, repair vs replacement and how to best shape the future of MR and TR treatment. The AV… View more

Imaging & Diagnostics

Intervention
Author(s): Manuel J Antunes Added: 3 years ago
After the advent of the heart–lung machine, which permitted open-heart surgery, in 1953, valve surgery was one of the most important advances in cardiac surgery. Initially, only conservative procedures were possible, but the first orthotopic human implantation of an artificial valve, by Starr in 1960, permitted the replacement of most cardiac valves not amenable to repair. Since then, more than a… View more

Intervention
TCT 23: Late-Breaking Clinical Trials Revealed
Added: 6 months ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more
Patrizio Lancellotti
Research Area(s) / Expertise: Job title: Head of the Cardiology Department
Personal History In 1970, Professor Lancellotti was born in Charleroi, Belgium to parents of Neapolitan origin.7, 8 He studied chemistry at the University of Labour Paul Pastur and graduated as a technician in 1988.7 It was his fascination with the heart and its physiology that drew him to cardiology and he has “always found that the heart was a noble organ.”9 Alongside Professor Gach and… View more
Author(s): Eduardo Alegria-Barrero , Olaf W Franzen Added: 3 years ago
Diseases of the mitral valve (MV) are the second most frequent clinically significant form of valvular disease in adults. In particular, MV regurgitation occurs with increasing frequency as part of degenerative changes in the ageing process.1 The annual incidence of degenerative MV disease is estimated at approximately 2–3 %. In addition to degenerative valve disease, MV regurgitation can be… View more

Vascular Disease and Surgery

Heart Failure